This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

China unveils plan for digital, intelligent overhaul of pharmaceutical sector

( April 25, 2025, 05:32 GMT | Official Statement) -- MLex Summary: Seven Chinese government agencies including those overseeing industry and information technology, health, medical products, and data administration have unveiled a five-year plan to achieve a digital and intelligent overhaul of the pharmaceutical industry. The agenda calls for boosting R&D in digital and intelligent technologies, constructing innovative platforms for large-scale pharmaceutical models, and developing key application scenarios. It also seeks to unlock the value of pharma data by generating high-quality datasets, enhancing data sharing and standardizing cross-border data-transfer management. Local authorities are expected to deploy advanced tools — such as video recognition, blockchain, Big Data and artificial intelligence — to sharpen regulatory oversight. The statement follows and the typical application scenarios are attached: ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login